» Articles » PMID: 23372574

Premature and Accelerated Aging: HIV or HAART?

Overview
Journal Front Genet
Date 2013 Feb 2
PMID 23372574
Citations 75
Authors
Affiliations
Soon will be listed here.
Abstract

Highly active antiretroviral therapy (HAART) has significantly increased life expectancy of the human immunodeficiency virus (HIV)-positive population. Nevertheless, the average lifespan of HIV-patients remains shorter compared to uninfected individuals. Immunosenescence, a current explanation for this difference invokes heavily on viral stimulus despite HAART efficiency in viral suppression. We propose here that the premature and accelerated aging of HIV-patients can also be caused by adverse effects of antiretroviral drugs, specifically those that affect the mitochondria. The nucleoside reverse transcriptase inhibitor (NRTI) antiretroviral drug class for instance, is known to cause depletion of mitochondrial DNA via inhibition of the mitochondrial specific DNA polymerase-γ. Besides NRTIs, other antiretroviral drug classes such as protease inhibitors also cause severe mitochondrial damage by increasing oxidative stress and diminishing mitochondrial function. We also discuss important areas for future research and argue in favor of the use of Caenorhabditis elegans as a novel model system for studying these effects.

Citing Articles

Lower immune senescence of T cell subsets among virologically suppressed Chinese men who have sex with men living with HIV in comparison with those ART naive.

Li L, Yu F, Yang S, Li H, Tang Y, Ma C BMC Infect Dis. 2025; 25(1):290.

PMID: 40021989 PMC: 11869689. DOI: 10.1186/s12879-025-10511-7.


Predicting Trajectories of Everyday Functioning in Adults Aging with HIV Using Latent Growth Mixture Modeling.

Ham L, Roesch S, Franklin D, Ellis R, Grant I, Moore D AIDS Behav. 2025; .

PMID: 39928071 DOI: 10.1007/s10461-025-04623-z.


Differential associations of anti-cytomegalovirus antibodies and soluble CD14 levels with immunosenescence in people living with HIV on long term antiretroviral therapy.

Shete A, Shidhaye P, Rao A, Bhawari N, Deshpande S, Sawant J Immun Ageing. 2024; 21(1):87.

PMID: 39709460 PMC: 11662588. DOI: 10.1186/s12979-024-00491-8.


The transcription factor PAX5 activates human LINE1 retrotransposons to induce cellular senescence.

Tang H, Yang J, Xu J, Zhang W, Geng A, Jiang Y EMBO Rep. 2024; 25(8):3263-3275.

PMID: 38866979 PMC: 11315925. DOI: 10.1038/s44319-024-00176-9.


A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation.

League A, Yadav-Samudrala B, Kolagani R, Cline C, Jacobs I, Manke J Front Immunol. 2024; 15:1374301.

PMID: 38835765 PMC: 11148243. DOI: 10.3389/fimmu.2024.1374301.


References
1.
Faraj A, Fowler D, Bridges E, Sommadossi J . Effects of 2',3'-dideoxynucleosides on proliferation and differentiation of human pluripotent progenitors in liquid culture and their effects on mitochondrial DNA synthesis. Antimicrob Agents Chemother. 1994; 38(5):924-30. PMC: 188128. DOI: 10.1128/AAC.38.5.924. View

2.
Guaraldi G, Orlando G, Zona S, Menozzi M, Carli F, Garlassi E . Premature age-related comorbidities among HIV-infected persons compared with the general population. Clin Infect Dis. 2011; 53(11):1120-6. DOI: 10.1093/cid/cir627. View

3.
Lewis W, Dalakas M . Mitochondrial toxicity of antiviral drugs. Nat Med. 1995; 1(5):417-22. DOI: 10.1038/nm0595-417. View

4.
Caron-Debarle M, Lagathu C, Boccara F, Vigouroux C, Capeau J . HIV-associated lipodystrophy: from fat injury to premature aging. Trends Mol Med. 2010; 16(5):218-29. DOI: 10.1016/j.molmed.2010.03.002. View

5.
Marzolini C, Back D, Weber R, Furrer H, Cavassini M, Calmy A . Ageing with HIV: medication use and risk for potential drug-drug interactions. J Antimicrob Chemother. 2011; 66(9):2107-11. DOI: 10.1093/jac/dkr248. View